In the most recent edition of our Global Healthcare Transactions Series, we focus on the Asia-Pacific region, which saw a wave of healthcare activity in 2020 including record high deals and a new peak for disclosed value. These gains can be attributed to macroeconomic trends such as aging populations and increasingly affordable healthcare, and favorable government policies encouraging local manufacturing and development of healthcare products.
For more details on the below topics, read the full LawFlash.
- Valuation and purchase price
- Legal due diligence
- Termination, force majeure, and material adverse change
- Representations, warranties, and indemnities
- Change of law clauses
Our global healthcare industry team continues to highlight the global impact of COVID-19 on healthcare transactions. View our previous publication for more insight: How COVID-19 Impacted Transactions in the United States.